Pharmaceutics (Nov 2023)

Stability Studies of Antipseudomonal Beta Lactam Agents for Outpatient Therapy

  • Beatriz Fernández-Rubio,
  • Laura Herrera-Hidalgo,
  • Arístides de Alarcón,
  • Rafael Luque-Márquez,
  • Luis E. López-Cortés,
  • Sònia Luque,
  • José María Gutiérrez-Urbón,
  • Aurora Fernández-Polo,
  • Alicia Gutiérrez-Valencia,
  • María V. Gil-Navarro

DOI
https://doi.org/10.3390/pharmaceutics15122705
Journal volume & issue
Vol. 15, no. 12
p. 2705

Abstract

Read online

Outpatient parenteral antimicrobial therapy (OPAT) is a useful treatment strategy against Pseudomonas aeruginosa and other multidrug-resistant bacteria. However, it is hindered by the lack of stability data for the administration of antibiotics under OPAT conditions. Our objective was to investigate the stability of nine antipseudomonal and broad-spectrum beta lactam antibiotics (aztreonam, cefepime, cefiderocol, ceftazidime, ceftazidime/avibactam, ceftolozane/tazobactam, meropenem, meropenem/vaborbactam, and piperacillin/tazobactam) to allow the spread of OPAT programs. All the antibiotics were diluted in 500 mL 0.9% sodium chloride and stored at 4, 25, 32, and 37 °C for 72 h in two different devices (infusion bags and elastomeric pumps). The solutions were considered stable if the color, clearness, and pH remained unchanged and if the percentage of intact drug was ≥90%. All the antimicrobials remained stable 72 h under refrigerated conditions and at least 30 h at 25 °C. At 32 °C, all the antibiotics except for meropenem and meropenem/vaborbactam remained stable for 24 h or more. At 37 °C, only aztreonam, piperacillin/tazobactam, cefepime, cefiderocol, and ceftolozane/tazobactam were stable for at least 24 h. The stability results were the same in the two devices tested. All the antibiotics studied are actual alternatives for the treatment of antipseudomonal or multidrug-resistant infections in OPAT programs, although the temperature of the devices is crucial to ensure antibiotic stability.

Keywords